News | Women's Health | August 01, 2017

The ACR-accredited breast imaging center installs Fujifilm's ASPIRE Cristalle, the digital FFDM system with DBT

The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow

Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast imaging center based in Monterey, Cali., has installed Fujifilm’s ASPIRE Cristalle FFDM system with Digital Breast Tomosynthesis (DBT). The innovative 3-D breast imaging technology has been in use at the center since April.

“We are pleased and excited that The Mammography Center has selected Fujifilm’s ASPIRE Cristalle with DBT. It is especially gratifying to know that women in the Monterey area have access to advanced technology such as breast tomosynthesis in their own community,” said Rob Fabrizio, director of strategic marketing, digital radiography and women’s health, Fujifilm Medical Systems U.S.A., Inc. “We look forward to continuing to support The Mammography Center of Monterey in their efforts to educate women and build awareness about the benefits of 3-D mammography with both clinicians and patients.”

In business for 28 years, The Mammography Center of Monterey was seeking to expand its offerings with the latest mammography technology. The facility decided to make an investment in the latest advanced technology versus staying with a traditional 2-D system. After evaluating competitive breast tomosynthesis units—and speaking with both a technologist and a radiologist familiar with the ASPIRE Cristalle—the facility opted for Fujifilm’s ASPIRE Cristalle.

“Radiologists at the center are impressed with the technology and their ability to clearly see details, especially in images of dense breast tissue,” said Mary Lou Catania, RN, founder and president, The Mammography Center of Monterey.

According to Catania, since the center began using ASPIRE Cristalle with DBT, recall rates have dropped and in fact, there have been no patients recalled due to dense breast images.

Catania also stated that the Fujifilm system is easy-to-use, comfortable for patients, and affordable. She credits the company with a smooth installation and excellent training, saying technologists quickly got up to speed on the ASPIRE Cristalle and were able to rapidly get back on track performing a backlog of patient exams.

The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow to optimize patient dose while maximizing image quality.

For more information: www.fujimed.com

 


Related Content

News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
Subscribe Now